# Reduced-dose Versus Standard Dose Radiotherapy for Nasopharyngeal Carcinomain

> **NCT05304468** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 452 (actual)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **RADIATION:** IMRT
- **DRUG:** induction chemotherapy
- **DRUG:** cisplatin concurrent chemotherapy

## Key facts

- **NCT ID:** NCT05304468
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-05-11
- **Primary completion:** 2026-10-29
- **Final completion:** 2029-10-29
- **Target enrollment:** 452 (ACTUAL)
- **Last updated:** 2025-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05304468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05304468, "Reduced-dose Versus Standard Dose Radiotherapy for Nasopharyngeal Carcinomain". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05304468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*